Zum Inhalt springen
Home » T2 Biosystems Announces CRG’s Conversion from Preferred Stock to Common Stock

T2 Biosystems Announces CRG’s Conversion from Preferred Stock to Common Stock

LEXINGTON, Mass., May 14, 2024 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced that entities affiliated with CRG Servicing LLC (“CRG”) have converted Series A and Series B Convertible Preferred Stock to Common Stock.

T2 Biosystems Announces CRG’s Conversion from Preferred Stock to Common Stock